Camilla Huse Bondesson
Camilla Huse Bondesson has over thirty years of international experience within the fields of biotech-tools, IVD, MedTech and biotechnology. She has held senior positions, including CEO, and worked for large and small companies such as CellSeed, Pathogenomics, Invitrogen, Behring Diagnostica, Biacore, Gyros and Amersham Pharmacia Biotech (today GE LifeSciences). Her focus is on commercialization and the ‘go-to-market’ process, including marketing, sales and business development. She has an Executive MBA from Stockholm University. Since 2004 Camilla is working as a consultant and partner at Conlega AB, a consulting company focusing on helping Life Science companies to plan and execute for growth. Alongside consultancy engagements, Camilla is currently Chairman of the Board of Gradientech AB, Immuneed AB and TdB Consultancy AB, as well as board member of 2cureX AB.
Helena Ströberg, M.Sc., Business Development. “I am passionate about creating opportunities so that players in the life science industry become more successful, thus contributing to growth in our region as well as in Sweden.”